Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - desogestrel - film coated tablets - desogestrel 0.075 mg - desogestrel - desogestrel - contraceptive.

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - ezetimibe - tablets - ezetimibe 10 mg - ezetimibe - ezetimibe - primary hypercholesterolemia: ezetrol administered with an hmg-coa reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. homozygous familial hypercholesterolemia (hofh): ezetrol administered with a statin are indicated for use in patients with hofh.patients may also receive adjunctive treatments (e.g. ldl apheresis).homozygous sitosterolemia (phytosterolemia): ezetrol are indicated for use in patients with homozygous familial sitosterolemia.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

organon laboratories limited - dexamethasone sodium phosphate - withdrawn form - 2 millilitre

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - desogestrel; ethinylestradiol - tablets - desogestrel 150 mcg; ethinylestradiol 20 mcg - desogestrel - desogestrel - oral contraception

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - tablets - montelukast as sodium 10 mg - montelukast - montelukast - singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - ointment - salicylic acid 30 mg/g; betamethasone as dipropionate 0.5 mg/g - betamethasone - betamethasone - provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - lotion - salicylic acid 20 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, other combinations - provides anti-inflammatory, antipruritic, anti-allergic and keratinolytic activity in the topical management of subacute and chronic hyperkeratotic and dry dermatoses responsive to corticosteroid therapy

Israël - anglais - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin as sulfate - ointment - betamethasone as dipropionate 0.5 mg / 1 g; gentamicin as sulfate 1 mg / 1 g - topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to gentamicin